Sanofi sells controlling stake of consumer healthcare business Opella Ruchika Sharma2 May 2025 3:35 PM ISTParis: Sanofi has announced the closing of the sale to CD&R of a 50.0% controlling stake of its consumer healthcare business Opella. Sanofi...
Sanofi invests Euro 15 milion in Innate Pharma Ruchika Sharma25 April 2025 2:30 PM ISTMarseille: Innate Pharma SA has announced a €14,999,998.59 capital increase subscribed by Sanofi.As announced on April 23, 2025, and given the...
Sanofi, Regeneron Pharma secures USFDA approval for Dupixent for chronic spontaneous urticaria Ruchika Sharma19 April 2025 1:15 PM ISTParis: Sanofi and Regeneron Pharma have received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the...
USFDA grants orphan drug designation to Sanofi Rilzabrutinib for two rare diseases Ruchika Sharma3 April 2025 2:45 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to Rilzabrutinib, an...
Sanofi Dupixent approved in Japan for COPD Ruchika Sharma30 March 2025 10:00 AM ISTDupixent is intended for injection under the skin (subcutaneous injection) and is given every other week.
USFDA approves Sanofi Qfitlia for hemophilia A or B with or without inhibitors Ruchika Sharma29 March 2025 11:30 AM ISTParis: Sanofi has announced that the Company has received approval from the US Food and Drug Administration (FDA) for Qfitlia...
Sanofi gets USFDA fast track designation for Chlamydia vaccine candidate Ruchika Sharma27 March 2025 3:22 PM ISTParis: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate for the...
Sanofi Tolebrutinib under USFDA priority review for multiple sclerosis Ruchika Sharma25 March 2025 12:15 PM ISTTolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority.
Sanofi to buy Autoimmune Disease treatment from Dren Bio for up to USD 1.9 billion Ruchika Sharma20 March 2025 11:30 AM ISTParis: Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi...
Sanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma Ruchika Sharma27 Feb 2025 11:30 AM ISTParis: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with...
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid Ruchika Sharma20 Feb 2025 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license...
Sanofi acquires 2.3% of its shares from long-standing shareholder L'Oréal Ruchika Sharma4 Feb 2025 1:06 PM ISTParis: Sanofi has announced the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s...
